Delivery Order SPE2DB24D1006-SPE2DB25FCFAE
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,702.70 for Teriparatide 560mcg/2.24ml pen on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Teriparatide is a recombinant human parathyroid hormone used primarily in the treatment of osteoporosis, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $14,317.78 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used primarily in the treatment of osteoporosis and bone-related conditions. This...
- The Defense Logistics Agency awarded a $3,475.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens, with an ultimate completion date of September 9, 2025. This non-set-aside contract was competitively awarded on September 8, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a synthetic form of parathyroid hormone used to treat osteoporosis and promote bone formation,...
- The Defense Logistics Agency awarded a $51,334.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with performance in Conshohocken, Pennsylvania and a completion date of September 4, 2025. This non-set-aside delivery order was competitively awarded and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. Teriparatide is a recombinant human...
- The Defense Logistics Agency awarded a $26,852.75 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This contract represents a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,423.09 for Teriparatide 560mcg/2.24ml pen on a firm fixed price basis. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025. No set-aside designation was used for this competitive award. Teriparatide is a recombinant human parathyroid hormone used to treat osteoporosis and related bone conditions in eligible patient populations. This delivery order...
- The Defense Logistics Agency awarded a $3,468.94 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of July 30, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,322.26 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pens on May 27, 2025. This competitively awarded, firm fixed-price delivery order is structured with an ultimate completion date of May 28, 2025, and carries no set-aside designation. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human...
- The Defense Logistics Agency awarded a delivery order valued at $5,192.53 to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pen injections, with performance in Conshohocken, Pennsylvania and completion by August 27, 2025. This award represents a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 26, 2025. The contract supplies a pharmaceutical product used primarily for osteoporosis treatment, supporting the federal medical supply chain for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,569.17 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...